This question has been on my mind since I decided over a year ago to look for an investment partner to help with a major expansion of Kolmac. Our chosen partner, WindRose Health Investors, has spent the past 3 months adding administrative infrastructure to create… Read More

Irrational exuberance is not to be addressed lightly. Nevertheless, after seeing so much misinformation about the possible therapeutic benefits of cannabidiol (CBD) being circulated, I thought that now would be a good time to list some of the established facts that we have about this… Read More

Is regular use of cannabis (aka marijuana) bad for young brains? The short answer is probably “yes.” How severe and how permanent is the damage? – those are the next questions that need to be addressed. Our ability to answer these important questions accurately has… Read More

How can the Food and Drug Administration approve a new potent opioid pain medication at a time when the opioid epidemic continues to claim an increasing number of lives due to opioid overdose? That is the question being raised by critics of this recent decision…. Read More

“To leave the field of addiction treatment better than when we found it” has always been an important part of Kolmac’s mission. The development of our organization over the past 45 years can be divided into the following chapters. Chapter 1. 1973 to 1983: Establishing… Read More

Last week I had the opportunity to give a talk on medical cannabis to members of the Montgomery County Medical Society. What struck me about the physicians in attendance was their high level of interest, as well as their concern about how little information they… Read More

I am writing this article as I return from the funeral of Dr. Herb Kleber, who died at the age of 84 on October 5th.  During his 50-year professional career, Herb’s clinical and administrative achievements in the field of addictions were remarkable in their breadth:… Read More